Title of the panel discussion:
Speed to Clinic: Global Perspectives on Conducting Clinical Trials in Switzerland, Hong Kong, Australia and the MENA Region
Panel discussion summary
Selecting the optimal location for early clinical trials can significantly influence the speed and success of biotech innovation. This panel will bring together key stakeholders from leading and emerging international ecosystems to discuss opportunities, regulatory pathways, and practical considerations for executing clinical trials across jurisdictions.
Date, time and room information
Tuesday, May 5, 14:30 - 15:15, room Osaka/Samarkand
Moderation
| Name | Position | Institution |
|---|---|---|
| Simone Ferbitz-Scheurer | Head of Clinical Trials Division | Swissmedic |
Panelists
| Name | Position | Institution |
|---|---|---|
| Stella Sun | Principal Manager Life & Health Sciences | InvestHK |
| Eric Adam | COO | HAYA Therapeutics |
| Racha Fayad | Life Sciences Strategy Team | KPMG |
| Shu Lam | Chief Business Development Officer | CMAX Clinical Research |
| Christel Gremion Viatte | Director Global Regulatory CTA | CSL |
Global Village program
This panel discussion is part of the Global Village program
